Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
XDNEWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
B.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
MD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
LF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
KR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
MD.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
EG.5.1.16ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
GS.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
GK.1.10ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JE.1.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
GJ.5ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JG.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JR.1.1.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JG.3.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
HK.8ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
EG.5.1.12ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
XDD.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
HK.3.2.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
EG.4.5ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JJ.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
HN.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
GJ.1.2.7ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
XCLORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
FL.20.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JN.1.10ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
HV.1.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
JN.1.12ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
XDNORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
FT.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-2358.39Japan
B.1.277NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-2353.5Germany
BC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-2346.71France
B.1.444NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-2319.66Japan
BQ.1.1.56ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-2316.24Singapore
B.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-2308.74South Korea
XDNSChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
LH.2SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
JN.1.65SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
XDZSChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
JN.1.25SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
JN.2.5SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
KY.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
JN.2.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-2296.22China
XCHSWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-2292.98Japan
BA.5.2.44ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-2272.2France
BA.5.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-2272.2France
BA.5.2.35ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-2272.2France
XAQECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-2266.25Germany
BM.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-2266.25Germany
HN.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-2266.25Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used